LENALIDOMIDE AND RITUXIMAB (ReRi) AS FRONT LINE THERAPY OF ELDERLY FRAIL PATIENTS WITH DIFFUSE LARGE B-CELLS LYMPHOMA. FIRST PLANNED INTERIM ANALYSIS OF A PHASE II STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FIL)

Authors :: Guido Gini
Renato Bassan
Anna Marina Liberati
Sergio Storti
M. Sampaolo
Francesca Re
C. Visco
Ombretta Annibali
Annalisa Arcari
Stefano Luminari
Alessandra Tucci
Francesco Merli
Gerardo Musuraca
Angelo Fabbri
Filippo Ballerini
Maria Christina Cox
Monica Tani
Vittorio Ruggero Zilioli
Source :: Hematological Oncology. 37:427-428
Publication Year :: 2019
Publisher :: Wiley, 2019.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Phases of clinical research
Front line
Hematology
General Medicine
medicine.disease
Interim analysis
Lymphoma
Internal medicine
Medicine
Rituximab
Frail elderly
business
medicine.drug
Lenalidomide

Full Text Access

Tools